NLS Pharmaceutics to Participate in the B. Riley Annual Neuro & Ophthalmology Investor Conference
Press release content from Accesswire. The AP news staff was not involved in its creation.
Source: apnews.com
Page 3 - Pascal Nigen News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Pascal Nigen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Pascal Nigen Today - Breaking & Trending Today
NLS Pharmaceutics AG: NLS Pharmaceutics Ltd. Announces US$4.4 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
ZURICH, SWITZERLAND / ACCESSWIRE / April 13, 2022 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery
Source: finanznachrichten.de
NLS Pharmaceutics AG: NLS Pharmaceutics Announces Receipt of Notice of Deficiency with Nasdaq Continued Listing Requirements
ZURICH, SWITZERLAND / ACCESSWIRE / April1, 2022 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery
Source: finanznachrichten.de
NLS Pharmaceutics AG: NLS Pharmaceutics Retains LifeSci Partners As Financial Advisor To Evaluate Strategic Partnering Initiatives
ZURICH, SWITZERLAND / ACCESSWIRE / March 31, 2022 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery
Source: finanznachrichten.de
NLS Pharmaceutics AG: NLS Pharmaceutics to Participate in Maxim Group 2022 Virtual Growth Conference
ZURICH, SWITZERLAND / ACCESSWIRE / March 25, 2022 - NLS Pharmaceutics Ltd. (Nasdaq:NLSP, NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development
Source: finanznachrichten.de